Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hackett

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Genes & Development|August 3, 2012
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsXi Huang, Adrian M Dubuc, Rintaro Hashizume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanomaKam Fai Tse, Michael Jeffers, Vincent A Pollack, et al.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Clinical and Experimental Immunology|June 22, 2013
A UK national audit of hereditary and acquired angioedemaS Jolles, P Williams, E Carne, et al.
Cancer Cell|December 12, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunityYihan Zuo, David J Vohwinkel, Bowen Dong, et al.
Genes & Development|May 19, 2010
Pleiotropic role for MYCN in medulloblastomaFredrik J Swartling, Matthew R Grimmer, Christopher S Hackett, et al.
Cancer Research|September 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung TumorigenesisAria Vaishnavi, Joseph Juan, Maebh Jacob, et al.
Clinical and Translational Radiation Oncology|July 26, 2019
Adaptive radiotherapy: The Elekta Unity MR-linac conceptDennis Winkel, Gijsbert H Bol, Petra S Kroon, et al.
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Genes & Development|August 3, 2012
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsXi Huang, Adrian M Dubuc, Rintaro Hashizume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanomaKam Fai Tse, Michael Jeffers, Vincent A Pollack, et al.
Nature Cancer|July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuitFei Yi, Tal Cohen, Natalie Zimmerman, et al.
Clinical and Experimental Immunology|June 22, 2013
A UK national audit of hereditary and acquired angioedemaS Jolles, P Williams, E Carne, et al.
Cancer Cell|December 12, 2025
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunityYihan Zuo, David J Vohwinkel, Bowen Dong, et al.
Genes & Development|May 19, 2010
Pleiotropic role for MYCN in medulloblastomaFredrik J Swartling, Matthew R Grimmer, Christopher S Hackett, et al.
Cancer Research|September 16, 2022
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung TumorigenesisAria Vaishnavi, Joseph Juan, Maebh Jacob, et al.
Clinical and Translational Radiation Oncology|July 26, 2019
Adaptive radiotherapy: The Elekta Unity MR-linac conceptDennis Winkel, Gijsbert H Bol, Petra S Kroon, et al.
Cell Reports|December 2, 2014
Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastomaChristopher S Hackett, David A Quigley, Robyn A Wong, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
Pageof 15